Engineering Lactic Acid Bacteria and Bifidobacteria for Mucosal Delivery of Health Molecules

Biotechnology of Lactic Acid Bacteria: Novel Applications: Second Edition

Volumn , Issue , 2015, Pages 170-190

  Allain, Thibault ^a   Aubry, Camille ^a   Natividad, Jane M ^a   Chatel, Jean Marc ^a   Langella, Philippe ^a   Bermúdez Humarán, Luis G ^a  

^a UMR1319 MICALIS   (France)

Author keywords

Autoimmune diseases; Bifidobacteria; Food allergy; Genetic tools; Health molecules; Infectious diseases; Lactic acid bacteria; Lactococcus lactis; Mucosal delivery; Therapeutic applications

Indexed keywords

BACTERIA; LABORATORIES; LACTIC ACID; MOLECULES; PROTEINS;

AUTOIMMUNE DISEASE; BIFIDOBACTERIA; FOOD ALLERGIES; GENETIC TOOLS; INFECTIOUS DISEASE; LACTIC ACID BACTERIA; LACTOCOCCUS LACTIS; MUCOSAL DELIVERY; THERAPEUTIC APPLICATION;

DISEASES;

EID: 84957959118     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118868386.ch11     Document Type: Chapter

References (135)

1. Ankarklev, J., Jerlstrom-Hultqvist, J., Ringqvist, E., et al. (2010) Behind the smile: cell biology and disease mechanisms of Giardia species. Nat Rev Microbiol 8, 413-422.
2. Bahey-El-Din, M., Griffin, B.T., and Gahan, C.G. (2008) Nisin inducible production of listeriolysin O in Lactococcus lactis NZ9000. Microb Cell Fact 7, 24.
3. Baranger, K., Zani, M.L., Labas, V., et al. (2011) Secretory leukocyte protease inhibitor (SLPI) is, like its homologue trappin-2 (pre-elafin), a transglutaminase substrate. PLoS One 6, e20976.
4. Baumgart, D.C. and Sandborn, W.J. (2007) Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 369, 1641-1657.
5. Benbouziane, B., Ribelles, P., Aubry, C., et al. (2013) Development of a stress-inducible controlled expression (SICE) system in Lactococcus lactis for the production and delivery of therapeutic molecules at mucosal surfaces. J Biotechnol 168, 120-129.
6. Berlett, B.S. and Stadtman, E.R. (1997) Protein oxidation in aging, disease, and oxidative stress. J Biol Chem 272, 20313-20316.
7. Bermudez-Humaran, L.G. (2009) Lactococcus lactis as a live vector for mucosal delivery of therapeutic proteins. Human vaccines 5, 264-267.
8. Bermudez-Humaran, L.G., Cortes-Perez, N.G., Le Loir, Y, et al. (2004) An inducible surface presentation system improves cellular immunity against human papillomavirus type 16 E7 antigen in mice after nasal administration with recombinant lactococci. J Med Microbiol 53, 427-433.
9. Bermudez-Humaran, L.G., Cortes-Perez, N.G., Lefevre, F., et al. (2005) A novel mucosal vaccine based on live lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against human papillomavirus type 16-induced tumors. J Immunol 175, 7297-7302.
10. Bermudez-Humaran, L.G., Kharrat, P., Chatel, J.M., and Langella, P. (2011) Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccines. Microb Cell Fact 10 Suppl 1, S4.
11. Bermudez-Humaran, L.G., Langella, P., Miyoshi, A., et al. (2002) Production of human papillomavirus type 16 E7 protein in Lactococcus lactis. Appl Environ Microbiol 68, 917-922.
12. Bolotin, A., Wincker, P., Mauger, S., et al. (2001) The complete genome sequence of the lactic acid bacterium Lactococcus lactis ssp. lactis IL1403. Genome Res 11, 731-753.
13. Braat, H., Rottiers, P., Hommes, D.W., et al. (2006) A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease. Clin Gastroenterol Hepatol 4, 754-759.
14. Bron, P.A., Benchimol, M.G., Lambert, J., et al. (2002) Use of the alr gene as a food-grade selection marker in lactic acid bacteria. Appl Environ Microbiol 68, 5663-5670.
15. Bruno-Barcena, J.M., Andrus, J.M., Libby, S.L., et al. (2004) Expression of a heterologous manganese superoxide dismutase gene in intestinal lactobacilli provides protection against hydrogen peroxide toxicity. Appl Environ Microbiol 70, 4702-4710.
16. Carroll, I.M., Andrus, J.M., Bruno-Barcena, J.M., et al. (2007) Anti-inflammatory properties of Lactobacillus gasseri expressing manganese superoxide dismutase using the interleukin 10-deficient mouse model of colitis. Amer J Physiol Gastroint Liver Physiol 293, G729-738.
17. Cenac, N., Andrews, C.N., Holzhausen, M., et al. (2007) Role for protease activity in visceral pain in irritable bowel syndrome. J Clin Invest 117, 636-647.
18. Chatel, J.M., Langella, P., Adel-Patient, K., et al. (2001) Induction of mucosal immune response after intranasal or oral inoculation of mice with Lactococcus lactis producing bovine beta-lactoglobulin. Clin Diagn Lab Immunol 8, 545-551.
19. Chatel, J.M., Nouaille, S., Adel-Patient, K., et al. (2003) Characterization of a Lactococcus lactis strain that secretes a major epitope of bovine beta-lactoglobulin and evaluation of its immunogenicity in mice. Appl Environ Microbiol 69, 6620-6627.
20. Chatel, J.M., Pothelune, L., Ah-Leung, S., et al. (2008) In vivo transfer of plasmid from food-grade transiting lactococci to murine epithelial cells. Gene Therapy 15, 1184-1190.
21. Chen, S.W., Zhong, J., and Huan, L.D. (2007) Expression of human insulin in lactic acid bacteria and its oral administration in non-obese diabetic mice. Wei Sheng Wu Xue Bao 47, 987-991.
22. Clifford, A.J., Wilson, D.S. and Bills, N.D. (1989) Repletion of folate-depleted rats with an amino acid-based diet supplemented with folic acid. J Nutr 119, 1956-1961.
23. Conte, M.P., Schippa, S., Zamboni, I., et al. (2006) Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease. Gut 55, 1760-1767.
24. Cortes-Perez, N.G., Ah-Leung, S., Bermudez-Humaran, L.G., et al. (2007) Intranasal coadministration of live lactococci producing interleukin-12 and a major cow's milk allergen inhibits allergic reaction in mice. Clin Vaccine Immunol 14, 226-233.
25. Cortes-Perez, N.G., Azevedo, V., Alcocer-Gonzalez, J.M., et al. (2005) Cell-surface display of E7 antigen from human papillomavirus type-16 in Lactococcus lactis and in Lactobacillus plantarum using a new cell-wall anchor from lactobacilli. J Drug Targ 13, 89-98.
26. Crittenden, R.G. and Bennett, L.E. (2005) Cow's milk allergy: a complex disorder. J Amer Col Nutr 24, 582S-591S.
27. de Azevedo, M., Karczewski, J., Lefevre, F., et al. (2012) In vitro and in vivo characterization of DNA delivery using recombinant Lactococcus lactis expressing a mutated form of L. monocytogenes Internalin A. BMC Microbiol 12, 299.
28. deVos, D., Clements, P., Pyke, S.M., et al. (1999) Characterisation and in vitro cytotoxicity of triorganophosphinegold(i) 2-mercaptobenzoate complexes. Metal-based Drugs 6, 31-40.
29. De Vos, W.M. and Gasson, M.J. (1989) Structure and Expression of the Lactococcus lactis Gene for Phospho-β- galactosidase (lacG) in Escherichia coli and L. lactis. Microbiology 135, 1833.
30. del Solar, G., Giraldo, R., Ruiz-Echevarria, M.J., et al. (1998) Replication and control of circular bacterial plasmids. Microbiol Mol Biol Rev 62, 434-464.
31. Dieye, Y., Oxaran, V., Ledue-Clier, F., et al. (2010) Functionality of sortase A in Lactococcus lactis. Appl Environ Microbiol 76, 7332-7337.
32. Eichenbaum, Z., Federle, M.J., Marra, D., et al. (1998) Use of the lactococcal nisA promoter to regulate gene expression in gram-positive bacteria: comparison of induction level and promoter strength. Appl Environ Microbiol 64, 2763.
33. Enouf, V., Langella, P., Commissaire, J., et al. (2001) Bovine rotavirus nonstructural protein 4 produced by Lactococcus lactis is antigenic and immunogenic. Appl Environ Microbiol 67, 1423-1428.
34. Exl, B.M. and Fritsche, R. (2001) Cow's milk protein allergy and possible means for its prevention. Nutrition 17, 642-651.
35. Farr, S.B. and Kogoma, T. (1991) Oxidative stress responses in Escherichia coli and Salmonella typhimurium. Microbiol Rev 55, 561-585.
36. Frossard, C.P., Steidler, L., and Eigenmann, P.A. (2007) Oral administration of an IL-10-secreting Lactococcus lactis strain prevents food-induced IgE sensitization. J Allergy Clin Immunol 119, 952-959.
37. Galipeau, H.J., Wiepjes, M., Motta, J.P., et al. (2014) Novel role of the serine protease inhibitor elafin in gluten-related disorders. Amer J Gastroenterol 109, 748-756.
38. Gerber, S.D. and Solioz, M. (2007) Efficient transformation of Lactococcus lactis IL1403 and generation of knock-out mutants by homologous recombination. J Basic Microbiol 47, 281-286.
39. Geriletu, Xu, R., Jia, H., et al. (2011) Immunogenicity of orally administrated recombinant Lactobacillus casei Zhang expressing Cryptosporidium parvum surface adhesion protein P23 in mice. Curr Microbiol 62, 1573-1580.
40. Gosselink, M.P., Schouten, W.R., van Lieshout, L.M., et al. (2004) Delay of the first onset of pouchitis by oral intake of the probiotic strain Lactobacillus rhamnosus GG. Dis Colon Rectum 47, 876-884.
41. Guimaraes, V.D., Innocentin, S., Lefevre, F., et al. (2006) Use of native lactococci as vehicles for delivery of DNA into mammalian epithelial cells. Appl Environ Microbiol 72, 7091-7097.
42. Halbmayr, E., Mathiesen, G., Nguyen, T.H., et al. (2008) High-level expression of recombinant beta-galactosidases in Lactobacillus plantarum and Lactobacillus sakei using a Sakacin P-based expression system. J Agric Food Chem 56, 4710-719.
43. Han, W., Mercenier, A., Ait-Belgnaoui, A., et al. (2006) Improvement of an experimental colitis in rats by lactic acid bacteria producing superoxide dismutase. Inflamm Bowel Dis 12, 1044-1052.
44. Hanson, M.L., Hixon, J.A., Li, W., et al. (2014) Oral delivery of IL-27 recombinant bacteria attenuates immune colitis in mice. Gastroenterology 146, 210-221 e213.
45. Huibregtse, I.L., Marietta, E.V., Rashtak, S., et al. (2009) Induction of antigen-specific tolerance by oral administration of Lactococcus lactis delivered immunodominant DQ8-restricted gliadin peptide in sensitized nonobese diabetic Abo Dq8 transgenic mice. J Immunol 183, 2390-2396.
46. Innocentin, S., Guimaraes, V., Miyoshi, A., et al. (2009) Lactococcus lactis expressing either Staphylococcus aureus fibronectin-binding protein A or Listeria monocytogenes internalin A can efficiently internalize and deliver DNA in human epithelial cells. Appl Environ Microbiol 75, 4870-4878.
47. Isolauri, E., Salminen, S., and Ouwehand, A.C. (2004) Microbial-gut interactions in health and disease. Probiotics. Best Pract Res Clin Gastroenterol 18, 299-313.
48. Iwaki, M., Okahashi, N., Takahashi, I., et al. (1990) Oral immunization with recombinant Streptococcus lactis carrying the Streptococcus mutans surface protein antigen gene. Infect Immun 58, 2929-2934.
49. Karlskas, I.L., Maudal, K., Axelsson, L., et al. (2014) Heterologous protein secretion in lactobacilli with modified pSIP vectors. PLoS One 9, e91125.
50. Kawana, K., Adachi, K., Kojima, S., et al. (2014) Oral vaccination against HPV E7 for treatment of cervical intraepithelial neoplasia grade 3 (CIN3) elicits E7-specific mucosal immunity in the cervix of CIN3 patients. Vaccine 2, 6233-6239.
51. Kellermayer, R. (2012) Epigenetics and the developmental origins of inflammatory bowel diseases. Can J Gastroenterol 26, 909-915.
52. Koc, M., Taysi, S., Emin Buyukokuroglu, M., and Bakan, N. (2003) The effect of melatonin against oxidative damage during total-body irradiation in rats. Radiat Res 160, 251-255.
53. Kristiansen, O.P., Zamani, M., Johannesen, J., et al. (1998) Linkage and association between a CD4 gene polymorphism and IDDM in Danish IDDM patients. The Danish IDDM Epidemiology and Genetics Group, and The Danish Study Group of Diabetes in Childhood. Diabetes 47, 281-283.
54. Kruidenier, L., van Meeteren, M.E., Kuiper, I., et al. (2003) Attenuated mild colonic inflammation and improved survival from severe DSS-colitis of transgenic Cu/Zn-SOD mice. Free Rad Biol Med 34, 753-765.
55. Kuipers, O.P., Beerthuyzen, M.M., Siezen, R.J., and De Vos, W.M. (1993) Characterization of the nisin gene cluster nisABTCIPR of Lactococcus lactis. Requirement of expression of the nisA and nisi genes for development of immunity. Eur J Biochem/FEBS 216, 281-291.
56. Le Loir, Y., Gruss, A., Ehrlich, S.D., and Langella, P. (1998) A nine-residue synthetic propeptide enhances secretion efficiency of heterologous proteins in Lactococcus lactis. J Bacteriol 180, 1895-1903.
57. Lebeer, S., Claes, I.J., and Vanderleyden, J. (2012) Anti-inflammatory potential of probiotics: lipoteichoic acid makes a difference. Trends Microbiol 20, 5-10.
58. LeBlanc, J.G., Aubry, C., Cortes-Perez, N.G., et al. (2013) Mucosal targeting of therapeutic molecules using genetically modified lactic acid bacteria: an update. FEMS Microbiol Lett 344, 1-9.
59. LeBlanc, J.G., del Carmen, S., Miyoshi, A., et al. (2011) Use of superoxide dismutase and catalase producing lactic acid bacteria in TNBS induced Crohn's disease in mice. J Biotechnol 151, 287-293.
60. LeBlanc, J.G., Ledue-Clier, F., Bensaada, M., et al. (2008) Ability of Lactobacillus fermentum to overcome host alpha- galactosidase deficiency, as evidenced by reduction of hydrogen excretion in rats consuming soya alpha-galacto- oligosaccharides. BMC Microbiol 8, 22.
61. Lee, P., Abdul-Wahid, A., and Faubert, G.M. (2009) Comparison of the local immune response against Giardia lamblia cyst wall protein 2 induced by recombinant Lactococcus lactis and Streptococcus gordonii. Microbes Infec/Institut Pasteur 11, 20-28.
62. Lee, P. and Faubert, G.M. (2006) Expression of the Giardia lamblia cyst wall protein 2 in Lactococcus lactis. Microbiology 152, 1981-1990.
63. Lei, H., Xu, Y., Chen, J., et al. (2010) Immunoprotection against influenza H5N1 virus by oral administration of enteric- coated recombinant Lactococcus lactis mini-capsules. Virology 407, 319-324.
64. Leon, F., Smythies, L.E., Smith, P.D., and Kelsall, B.L. (2006) Involvement of dendritic cells in the pathogenesis of inflammatory bowel disease. Adv Exper Med Biol 579, 117-132.
65. Levine, J.B. and Lukawski-Trubish, D. (1995) Extraintestinal considerations in inflammatory bowel disease. Gastroenterol Clin North America 24, 633-646.
66. Li, Y., Li, X., Liu, H., et al. (2014) Intranasal immunization with recombinant lactococci carrying human papillomavirus E7 protein and mouse interleukin-12 DNA induces E7-specific antitumor effects in C57BL/6 mice. Oncol Lett 7, 576-582.
67. Lih-Brody, L., Powell, S.R., Collier, K.P., et al. (1996) Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig Dis Sci 41, 2078-2086.
68. Llull, D. and Poquet, I. (2004) New expression system tightly controlled by zinc availability in Lactococcus lactis. Appl Environ Microbiol 70, 5398-5406.
69. Ma, Y, Liu, J., Hou, J., et al. (2014) Oral Administration of Recombinant Lactococcus lactis Expressing HSP65 and Tandemly Repeated P277 Reduces the Incidence of Type I Diabetes in Non-Obese Diabetic Mice. PLoS One 9, e105701.
70. Madsen, S.M., Arnau, J., Vrang, A., et al. (1999) Molecular characterization of the pH-inducible and growth phase- dependent promoter P170 of Lactococcus lactis. Mol Microbiol 32, 75-87.
71. Marelli, B., Perez, A.R., Banchio, C., et al. (2011) Oral immunization with live Lactococcus lactis expressing rotavirus VP8 subunit induces specific immune response in mice. J Virol Methods 175, 28-37.
72. Marinho, F.A., Pacifico, L.G., Miyoshi, A., et al. (2010) An intranasal administration of Lactococcus lactis strains expressing recombinant interleukin-10 modulates acute allergic airway inflammation in a murine model. Clin Exper Allergy 40, 1541-1551.
73. Marteau, P., Lepage, P., Mangin, I., et al. (2004) Review article: gut flora and inflammatory bowel disease. Alim Pharmacol Therapeut 20 Suppl 4, 18-23.
74. Mierau, I. and Kleerebezem, M. (2005) 10 years of the nisin-controlled gene expression system (NICE) in Lactococcus lactis. Appl Microbiol Biotechnol 68, 705-717.
75. Mierau, I., Leij, P., van Swam, I.,et al. (2005) Industrial-scale production and purification of a heterologous protein in Lactococcus lactis using the nisin-controlled gene expression system NICE: the case of lysostaphin. Microb Cell Fact 4, 15.
76. Miyoshi, A., Jamet, E., Commissaire, J., et al. (2004) A xylose-inducible expression system for Lactococcus lactis. FEMS Microbiol Lett 239, 205-212.
77. Miyoshi, A., Poquet, I., Azevedo, V., et al. (2002) Controlled production of stable heterologous proteins in Lactococcus lactis. Appl Environ Microbiol 68, 3141-3146.
78. Moorthy, G. and Ramasamy, R. (2007) Mucosal immunisation of mice with malaria protein on lactic acid bacterial cell walls. Vaccine 25, 3636-3645.
79. Morello, E., Bermudez-Humaran, L.G., Llull, D., et al. and Poquet, I. (2008) Lactococcus lactis, an efficient cell factory for recombinant protein production and secretion. J Mol Microbiol Biotechnol 14, 48-58.
80. Motta, J.P., Bermudez-Humaran, L.G., Deraison, C., et al. (2012) Food-grade bacteria expressing elafin protect against inflammation and restore colon homeostasis. Sci Translat Med 4, 158-144.
81. Motta, J.P., Magne, L., Descamps, D., et al. (2011) Modifying the protease, antiprotease pattern by elafin overexpression protects mice from colitis. Gastroenterology 140, 1272-1282.
82. Mu, D., Montalban-Lopez, M., Masuda, Y., and Kuipers, O.P. (2013) Zirex: a novel zinc-regulated expression system for Lactococcus lactis. Appl Environ Microbiol 79, 4503-4508.
83. Munger, K., Werness, B.A., Dyson, N., et al. (1989) Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J 8, 4099-4105.
84. Mylonaki, M., Rayment, N.B., Rampton, D.S., et al. (2005) Molecular characterization of rectal mucosa-associated bacterial flora in inflammatory bowel disease. Inflam Bowel Dis 11, 481-487.
85. Nga, B.H. (2005) Genome analysis of lactic acid bacteria in food fermentations and biotechnological applications. Curr Opin Microbiol 8, 307-312.
86. Nguyen, T.T., Nguyen, T.H., Maischberger, T., et al. (2011) Quantitative transcript analysis of the inducible expression system pSIP: comparison of the overexpression of Lactobacillus spp. beta-galactosidases in Lactobacillus plantarum. Microb Cell Fact 10, 46.
87. Norton, P.M., Wells, J.M., Brown, H.W., et al. (1997) Protection against tetanus toxin in mice nasally immunized with recombinant Lactococcus lactis expressing tetanus toxin fragment C. Vaccine 15, 616-619.
88. Nouaille, S., Ribeiro, L.A., Miyoshi, A., et al. (2003) Heterologous protein production and delivery systems for Lactococcus lactis. Genet Mol Res 2, 102-111.
89. Ott, S.J., Musfeldt, M., Wenderoth, D.F., et al. (2004) Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 53, 685-693.
90. Parashar, U.D., Hummelman, E.G., Bresee, J.S., et al. (2003) Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 9, 565-572.
91. Perez, C.A., Eichwald, C., Burrone, O., and Mendoza, D. (2005) Rotavirus vp7 antigen produced by Lactococcus lactis induces neutralizing antibodies in mice. J Appl Microbiol 99, 1158-1164.
92. Pontes, D., Azevedo, M., Innocentin, S., et al. (2014) Immune response elicited by DNA vaccination using Lactococcus lactis is modified by the production of surface exposed pathogenic protein. PLoS One 9, e84509.
93. Pontes, D., Innocentin, S., Del Carmen, S., et al. (2012) Production of Fibronectin Binding Protein A at the surface of Lactococcus lactis increases plasmid transfer in vitro and in vivo. PLoS One 7, e44892.
94. Pouwels, P.H., Leer, R.J., and Boersma, W.J. (1996) The potential of Lactobacillus as a carrier for oral immunization: development and preliminary characterization of vector systems for targeted delivery of antigens. J Biotechnol 44, 183-192.
95. Pouwels, P.H., Leer, R.J., Shaw, M., et al. (1998) Lactic acid bacteria as antigen delivery vehicles for oral immunization purposes. Int J Food Microbiol 41, 155-167.
96. Ramasamy, R., Yasawardena, S., Zomer, A., et al. (2006) Immunogenicity of a malaria parasite antigen displayed by Lactococcus lactis in oral immunisations. Vaccine 24, 3900-3908.
97. Robert, S., Gysemans, C., Takiishi, T., et al. (2014) Oral delivery of glutamic acid decarboxylase (GAD)-65 and IL10 by Lactococcus lactis reverses diabetes in recent-onset NOD mice. Diabetes 63, 2876-2887.
98. Robinson, K., Chamberlain, L.M., Lopez, M.C., et al. (2004) Mucosal and cellular immune responses elicited by recombinant Lactococcus lactis strains expressing tetanus toxin fragment C. Infect Immun 72, 2753-2761.
99. Robinson, K., Chamberlain, L.M., Schofield, K.M., et al. (1997) Oral vaccination of mice against tetanus with recombinant Lactococcus lactis. Nature Biotechnol 15, 653-657.
100. Roland, K.L. and Brenneman, K.E. (2013) Salmonella as a vaccine delivery vehicle. Expert review of vaccines 12, 1033-1045.
101. Ruddy, M.J., Wong, G.C., Liu, X.K., et al. (2004) Functional cooperation between interleukin-17 and tumor necrosis factor-alpha is mediated by CCAAT/enhancer-binding protein family members. J Biol Chem 279, 2559-2567.
102. Rush, C.M., Hafner, L.M., and Timms, P. (1995) Lactobacilli: vehicles for antigen delivery to the female urogenital tract. Advan Experim Med Biol 371B, 1547-1552.
103. Sallenave, J.M. (2010) Secretory leukocyte protease inhibitor and elafin/trappin-2: versatile mucosal antimicrobials and regulators of immunity. Amer J Respir Cell Mol Biol 42, 635-643.
104. Sarra, M., Pallone, F., Macdonald, T.T., and Monteleone, G. (2010) IL-23/IL-17 axis in IBD. Inflamm Bowel Dis 16, 1808-1813.
105. Schmid, M., Fellermann, K., Fritz, P., et al. (2007) Attenuated induction of epithelial and leukocyte serine antiproteases elafin and secretory leukocyte protease inhibitor in Crohn's disease. J Leukocyte Biol 81, 907-915.
106. Schotte, L., Steidler, L., Vandekerckhove, J., and Remaut, E. (2000) Secretion of biologically active murine interleukin-10 by Lactococcus lactis. Enz Microbial Technol 27, 761-765.
107. Segui, J., Gironella, M., Sans, M., et al. (2004) Superoxide dismutase ameliorates TNBS-induced colitis by reducing oxidative stress, adhesion molecule expression, and leukocyte recruitment into the inflamed intestine. J Leukocyte Biol 76, 537-544.
108. Serafini, F., Turroni, F., Guglielmetti, S., et al. (2012) An efficient and reproducible method for transformation of genetically recalcitrant bifidobacteria. FEMS Microbiol Lett 333, 146-152.
109. Shaw, L. and Wiedow, O. (2011) Therapeutic potential of human elafin. Biochem Soc Trans 39, 1450-1454.
110. Shi, S.H., Yang, W.T., Yang, G.L., et al. (2014) Immunoprotection against influenza virus H9N2 by the oral administration of recombinant Lactobacillus plantarum NC8 expressing hemagglutinin in BALB/c mice. Virology 464-465, 166-176.
111. Sokol, H., Pigneur, B., Watterlot, L., et al. (2008) Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci US A 105, 16731-16736.
112. Sorvig, E., Gronqvist, S., Naterstad, K., et al. (2003) Construction of vectors for inducible gene expression in Lactobacillus sakei and Lactobacillus plantarum. FEMS Microbiol Lett 229, 119-126.
113. Steidler, L., Robinson, K., Chamberlain, L., et al. (1998) Mucosal delivery of murine interleukin-2 (IL-2) and IL-6 by recombinant strains of Lactococcus lactis coexpressing antigen and cytokine. Infect Immun 66, 3183-3189.
114. Stepniak, D. and Koning, F. (2006) Celiac disease--sandwiched between innate and adaptive immunity. Human Immunol 67, 460-468.
115. Takiishi, T., Korf, H., Van Belle, T.L., et al. (2012) Reversal of autoimmune diabetes by restoration of antigen-specific tolerance using genetically modified Lactococcus lactis in mice. J Clin Invest 122, 1717-1725.
116. Tamboli, C.P., Caucheteux, C., Cortot, A., et al. (2003) Probiotics in inflammatory bowel disease: a critical review. Best Pract Res Clin Gastroenterol 17, 805-820.
117. Theisen, M., Soe, S., Brunstedt, K., et al. (2004) A Plasmodium falciparum GLURP-MSP3 chimeric protein; expression in Lactococcus lactis, immunogenicity and induction of biologically active antibodies. Vaccine 22, 1188-1198.
118. Tian, P., Ball, J.M., Zeng, C.Q., and Estes, M.K. (1996) The rotavirus nonstructural glycoprotein NSP4 possesses membrane destabilization activity. J Virol 70, 6973-6981.
119. van der Vossen, J.M., van der, Lelie, D. and Venema, G. (1987) Isolation and characterization of Streptococcus cremoris Wg2-specific promoters. Appl Environ Microbiol 53, 2452-2457.
120. van Roosmalen, M.L., Kanninga, R., El Khattabi, M., et al. (2006) Mucosal vaccine delivery of antigens tightly bound to an adjuvant particle made from food-grade bacteria. Methods 38, 144-149.
121. Vandenplas, Y., De Greef, E., and Devreker, T. (2014) Treatment of Cow's Milk Protein Allergy. Ped Gastroenterol Hepatol Nutr 17, 1-5.
122. Ward, R.L. (2008) Rotavirus vaccines: how they work or don't work. Exp Rev Mol Med 10, e5.
123. Watterlot, L., Rochat, T., Sokol, H., et al. (2010) Intragastric administration of a superoxide dismutase-producing recombinant Lactobacillus casei BL23 strain attenuates DSS colitis in mice. Int J Food Microbiol 144, 35-41.
124. Wegmann, U., O'Connell-Motherway, M., Zomer, A., et al. (2007) Complete genome sequence of the prototype lactic acid bacterium Lactococcus lactis subsp. cremoris MG1363. J Bacteriol 189, 3256-3270.
125. Weitzman, S.A. and Gordon, L.I. (1990) Inflammation and cancer: role of phagocyte-generated oxidants in carcinogenesis. Blood 76, 655-663.
126. Wells, J.M. and Mercenier, A. (2008) Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria. Nat Rev Microbiol 6, 349-362.
127. Wells, J.M., Wilson, P.W., Norton, P.M., et al. (1993a) Lactococcus lactis: high-level expression of tetanus toxin fragment C and protection against lethal challenge. Mol Microbiol 8, 1155-1162.
128. Wells, J.M., Wilson, P.W., Norton, P.M., et al. (1993b) Lactococcus lactis: high-level expression of tetanus toxin fragment C and protection against lethal challenge. Mol Microbiol 8, 1155-1162.
129. Whitehead, M., Ohlschlager, P., Almajhdi, F.N., et al. (2014) Human papillomavirus (HPV) type 16 E7 protein bodies cause tumour regression in mice. BMC Cancer 14, 367.
130. Wispe, J.R., Clark, J.C., Burhans, M.S., et al. (1989) Synthesis and processing of the precursor for human mangano- superoxide dismutase. Bioch Biophys Acta 994, 30-36.
131. Wu, C., Yang, G., Bermudez-Humaran, L.G., et al. (2006) Immunomodulatory effects of IL-12 secreted by Lactococcus lactis on Th1/Th2 balance in ovalbumin (OVA)-induced asthma model mice. Int Immunopharmacol 6, 610-615.
132. Yoshimura, T., Takeda, A., Hamano, S., et al. (2006) Two-sided roles of IL-27: induction of Th1 differentiation on naive CD4+ T cells versus suppression of proinflammatory cytokine production including IL-23-induced IL-17 on activated CD4+ T cells partially through STAT3-dependent mechanism. J Immunol 177, 5377-5385.
133. Zuo, F., Yu, R., Feng, X., et al. (2014) Combination of heterogeneous catalase and superoxide dismutase protects Bifidobacterium longum strain NCC2705 from oxidative stress. Appl Microbiol Biotechnol 98, 7523-7534.
134. Zurita-Turk, M., Del Carmen, S., Santos, A.C., et al. (2014) Lactococcus lactis carrying the pValac DNA expression vector coding for IL-10 reduces inflammation in a murine model of experimental colitis. BMC Biotechnol 14, 73.
135. Zwerschke, W. and Jansen-Durr, P. (2000) Cell transformation by the E7 oncoprotein of human papillomavirus type 16: interactions with nuclear and cytoplasmic target proteins. Adv Cancer Res 78, 1-29.